Neha Sutheekshna Anegondi

Title: Neha Sutheekshna Anegondi: Innovator in Geographic Atrophy Research

Introduction

Neha Sutheekshna Anegondi is a prominent inventor based in Fremont, CA. She has made significant contributions to the field of medical imaging and machine learning, particularly in the evaluation of geographic atrophy (GA) lesions in the retina. With a total of 3 patents, her work is paving the way for advancements in the diagnosis and treatment of retinal diseases.

Latest Patents

Neha's latest patents include innovative methods for predicting the progression of geographic atrophy. The first patent, titled "Prediction of geographic-atrophy progression using segmentation and feature evaluation," describes a method, system, and computer program product for evaluating a geographic atrophy lesion. This invention involves receiving an image of a GA lesion and determining a first set of values for shape features and a second set for textural features. The progression of GA is then predicted using these values.

The second patent, "Predicting geographic atrophy growth rate from fundus autofluorescence images using deep neural networks," focuses on evaluating geographic atrophy in the retina. This method involves receiving a set of fundus autofluorescence images and generating input for a machine learning system. The system predicts the lesion area and growth rate for the geographic atrophy lesion in the retina.

Career Highlights

Neha currently works at Genentech, Inc., where she applies her expertise in machine learning and medical imaging. Her innovative approaches have garnered attention in the medical community, contributing to the understanding and treatment of retinal diseases.

Collaborations

Some of Neha's notable coworkers include Simon Shang Gao and Jasmine Patil, who collaborate with her on various projects related to geographic atrophy research.

Conclusion

Neha Sutheekshna Anegondi is a trailblazer in the field of geographic atrophy research, with her patents reflecting her commitment to advancing medical technology. Her work continues to inspire innovation in the evaluation and treatment of retinal diseases.